Grace Fishel Junior Recital

https://dc.ewu.edu/music_performances/1694/thumbnail.jp

Use and misuse of evolutionary psychology in online manosphere communities: The case of female mating strategies

While early evolutionary accounts of female sexuality insisted on coyness and monogamous tendencies, evidence from the field of primatology started challenging those assumptions in the 1970s. Decades later, there exists many competing and overlapping hypotheses stressing the potential fitness benefits of female short-term and extra-pair mating. Female mammals are now seen as enacting varied and flexible reproductive strategies. This is both a victory for science, with a better fit between theory and reality, and for feminism, with the downfall of narrow stereotypes about female sexuality. However, evolutionary hypotheses on female mating strategies are routinely invoked among the antifeminist online communities collectively known as “the manosphere”. Based on the largest qualitative analysis of manosphere discourse to date, this study shows how these hypotheses are interpreted in sometimes violently misogynistic online spaces. Indeed, evolutionary scholars might be surprised to see sexist worldviews reinforced by the “dual mating strategy” and “sexy son” hypotheses, or by the latest research on the ovulatory cycle. The manosphere has its own version of Evolutionary Psychology, mingling cutting-edge scientific theories and hypotheses with personal narratives, sexual double standards, and misogynistic beliefs. After analyzing this phenomenon, this article suggests ways to mitigate it

Using tracer experiments to determine deep saline aquifers caprocks transport characteristics for carbon dioxide storage

It is shown how a simple gas tracer technique can contribute to the determination of transport characteristics of tight rock formations. Main obtained parameters are intrinsic permeability and the Klinkenberg coefficient; permeability as low as 10-21 m2 is easily attainable. Some information is also gained on diffusion characteristics and porosity. An example of application is given using caprocks from a deep saline aquifer in the Paris basin

Ferroan dolomitization by seawater interaction with mafic igneous dikes and carbonate host rock at the Latemar Platform, Dolomites, Italy: numerical modeling of spatial, temporal, and temperature data

Numerous publications address the petrogenesis of the partially dolomitized Latemar carbonate platform, Italy. A common factor is interpretation of geochemical data in terms of heating via regional igneous activity that provided kinetically favorable conditions for replacement dolomitization. New field, petrographic, XRD, and geochemical data demonstrate a spatial, temporal, and geochemical link between replacement dolomite and local mafic igneous dikes that pervasively intrude the platform. Dikes are dominated by strongly altered plagioclase and clinopyroxene. Significantly, where ferroan dolomite is present, it borders dikes. We hypothesize that seawater interacted with mafic minerals, causing Fe enrichment in the fluid that subsequently participated in dolomitization. This hypothesis was tested numerically through thermodynamic (MELTS, Arxim-GEM) and reactive flow (Arxim-LMA) simulations. Results confirm that seawater becomes Fe-enriched during interaction with clinopyroxene (diopside-hedenbergite) and plagioclase (anorthite-albite-orthoclase) solid solutions. Reaction of modified seawater with limestone causes ferroan and nonferroan replacement dolomitization. Dolomite quantities are strongly influenced by temperature. At 40 to 80 degrees C, ferroan dolomite proportions decrease with increasing temperature, indicating that Latemar dolomitization likely occurred at lower temperatures. This relationship between igneous dikes and dolomitization may have general significance due to the widespread association of carbonates with rifting-related igneous environments

Postoperative IMRT in head and neck cancer

BACKGROUND: Aim of this work was to assess loco-regional disease control in head and neck cancer (HNC) patients treated with postoperative intensity modulated radiation therapy (pIMRT). For comparative purposes, risk features of our series have been analysed with respect to histopathologic adverse factors. Results were compared with an own historic conventional radiation (3DCRT) series, and with 3DCRT and pIMRT data from other centres. Between January 2002 and August 2006, 71 patients were consecutively treated with pIMRT for a squamous cell carcinoma (SCC) of the oropharynx (32), oral cavity (22), hypopharynx (7), larynx (6), paranasal sinus (3), and an unknown primary, respectively. Mean and median follow up was 19 months (2–48), and 17.6 months. 83% were treated with IMRT-chemotherapy. Mean prescribed dose was 66.3 Gy (60–70), delivered with doses per fraction of 2–2.3 Gy, respectively. RESULTS: 2-year local, nodal, and distant control rates were 95%, 91%, and 96%, disease free and overall survival 90% and 83%, respectively. The corresponding survival rates for the subgroup of patients with a follow up time >12 months (n = 43) were 98%, 95%, 98%, 93%, and 88%, respectively. Distribution according to histopathologic risk features revealed 15% and 85% patients with intermediate and high risk, respectively. All loco-regional events occurred in the high risk subgroup. CONCLUSION: Surgery followed by postoperative IMRT in patients with substantial risk for recurrence resulted in high loco-regional tumor control rates compared with large prospective 3DCRT trials

Interventions for the treatment of oral cavity and oropharyngeal cancer:chemotherapy

<b>Background:</b> Oral cavity and oropharyngeal cancers are frequently described as part of a group of oral cancers or head and neck cancer. Treatment of oral cavity cancer is generally surgery followed by radiotherapy, whereas oropharyngeal cancers, which are more likely to be advanced at the time of diagnosis, are managed with radiotherapy or chemoradiation. Surgery for oral cancers can be disfiguring and both surgery and radiotherapy have significant functional side effects, notably impaired ability to eat, drink and talk. The development of new chemotherapy agents, new combinations of agents and changes in the relative timing of surgery, radiotherapy, and chemotherapy treatments may potentially bring about increases in both survival and quality of life for this group of patients.<p></p> <b>Objectives:</b> To determine whether chemotherapy, in addition to radiotherapy and/or surgery for oral cavity and oropharyngeal cancer results in improved survival, disease free survival, progression free survival, locoregional control and reduced recurrence of disease. To determine which regimen and time of administration (induction, concomitant or adjuvant) is associated with better outcomes.<p></p> <b>Search strategy:</b> Electronic searches of the Cochrane Oral Health Group's Trials Register, CENTRAL, MEDLINE, EMBASE, AMED were undertaken on 28th July 2010. Reference lists of recent reviews and included studies were also searched to identify further trials.<p></p> <b>Selection criteria:</b> Randomised controlled trials where more than 50% of participants had primary tumours in the oral cavity or oropharynx, and which compared the addition of chemotherapy to other treatments such as radiotherapy and/or surgery, or compared two or more chemotherapy regimens or modes of administration, were included.<p></p> <b>Data collection and analysis:</b> Trials which met the inclusion criteria were assessed for risk of bias using six domains: sequence generation, allocation concealment, blinding, completeness of outcome data, selective reporting and other possible sources of bias. Data were extracted using a specially designed form and entered into the characteristics of included studies table and the analysis sections of the review. The proportion of participants in each trial with oral cavity and oropharyngeal cancers are recorded in Additional Table 1.<p></p> <b>Main results:</b> There was no statistically significant improvement in overall survival associated with induction chemotherapy compared to locoregional treatment alone in 25 trials (hazard ratio (HR) of mortality 0.92, 95% confidence interval (CI) 0.84 to 1.00). Post-surgery adjuvant chemotherapy was associated with improved overall survival compared to surgery +/- radiotherapy alone in 10 trials (HR of mortality 0.88, 95% CI 0.79 to 0.99), and there was an additional benefit of adjuvant concomitant chemoradiotherapy compared to radiotherapy in 4 of these trials (HR of mortality 0.84, 95% CI 0.72 to 0.98). Concomitant chemoradiotherapy resulted in improved survival compared to radiotherapy alone in patients whose tumours were considered unresectable in 25 trials (HR of mortality 0.79, 95% CI 0.74 to 0.84). However, the additional toxicity attributable to chemotherapy in the combined regimens remains unquantified.<p></p> <b>Authors' conclusions:</b> Chemotherapy, in addition to radiotherapy and surgery, is associated with improved overall survival in patients with oral cavity and oropharyngeal cancers. Induction chemotherapy is associated with a 9% increase in survival and adjuvant concomitant chemoradiotherapy is associated with a 16% increase in overall survival following surgery. In patients with unresectable tumours, concomitant chemoradiotherapy showed a 22% benefit in overall survival compared with radiotherapy alone.<p></p&gt

IMRT in oral cavity cancer

BACKGROUND: Except for early T1,2 N0 stages, the prognosis for patients with oral cavity cancer (OCC) is reported to be worse than for carcinoma in other sites of the head and neck (HNC). The aim of this work was to assess disease outcome in OCC following IMRT. Between January 2002 and January 2007, 346 HNC patients have been treated with curative intensity modulated radiation therapy (IMRT) at the Department of Radiation Oncology, University Hospital Zurich. Fifty eight of these (16%) were referred for postoperative (28) or definitive (30) radiation therapy of OCC. 40 of the 58 OCC patients (69%) presented with locally advanced T3/4 or recurred lesions. Doses between 60 and 70 Gy were applied, combined with simultaneous cisplatin based chemotherapy in 78%. Outcome analyses were performed using Kaplan Meier curves. In addition, comparisons were performed between this IMRT OCC cohort and historic in-house cohorts of 33 conventionally irradiated (3DCRT) and 30 surgery only patients treated over the last 10 years. RESULTS: OCC patients treated with postoperative IMRT showed the highest local control (LC) rate of all assessed treatment sequence subgroups (92% LC at 2 years). Historic postoperative 3DCRT patients and patients treated with surgery alone reached LC rates of ~70–80%. Definitively irradiated patients revealed poorest LC rates with ~30 and 40% following 3DCRT and IMRT, respectively. T1 stage resulted in an expectedly significantly higher LC rate (95%, n = 19, p < 0.05) than T2-4 and recurred stages (LC ~50–60%, n = 102). Analyses according to the diagnosis revealed significantly lower LC in OCC following definitive IMRT than that in pharyngeal tumors treated with definitive IMRT in the same time period (43% vs 82% at 2 years, p < 0.0001), while the LC rate of OCC following postoperative IMRT was as high as in pharyngeal tumors treated with postoperative IMRT (>90% at 2 years). CONCLUSION: Postoperative IMRT of OCC resulted in the highest local control rate of the assessed treatment subgroups. In conclusion, generous indication for IMRT following surgical treatment is recommended in OCC cases with unfavourable features like tight surgical margin, nodal involvement, primary tumor stage >T1N0, or already recurred disease, respectively. Loco-regional outcome of OCC following definitive IMRT remained unsatisfactory, comparable to that following definitive 3DCRT